This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Flanagan, T. D. Articles by Barron, A. L. Search for Related Content PubMed Articles by Flanagan, T. D. Articles by Barron, A. L. Agricola Articles by Flanagan, T. D. Articles by Barron, A. L.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1970 February; 19(2): 360-366
Copyright © 1970 American Society for Microbiology. All Rights Reserved.

Plaque Formation by Mumps Virus and Inhibition by Antiserum

The Department of Microbiology, School of Medicine, State University of New York at Buffalo, Buffalo, New York 14214

ABSTRACT

Boston and ABC strains of mumps virus produced plaques approximately 1.0 mm in diameter in monolayers of BGM cells. The plaques were circular and either clear or target-like in form. Ricki strain virus produced plaques of similar size and form but, in addition, a red plaque was observed with this agent. The vaccine strain of mumps virus, Jeryl Lynn, produced minute clear plaques approximately 0.3 mm in diameter. Incorporation of diethylaminoethyl (DEAE)-dextran into the overlay medium did not affect the size difference between Jeryl Lynn plaques and those of the other strains. However plaques of the Jeryl Lynn and Ricki strains were more easily visualized when the overlay medium contained 400 µg/ml of DEAE-dextran. Simultaneous titration by plaque formation and roller tube infectivity showed that these two methods were of equal sensitivity. Virus neutralization by antibody was demonstrated by plaque reduction. Rise in antibody titer was observed in sera from human and animal infection, human vaccination, and rabbit immunization.